Abstract
Depression is the most common mental disorder, affecting a large population worldwide. Of the psychiatric syndromes which present mood disorders, major depressive disorder (MDD) is one of the most severe due to the long periods of depressed mood, somatic symptoms, cognitive disturbances, clinically significant distress and impairment in everyday functioning. The causes of MDD are complex and associated with environmental and biological aspects. Treatment comprises structured forms of psychotherapy and antidepressant medication but remission rates are low and justify the implementation of an alternative effective treatment. Various authors have associated physical exercise with the treatment of depression and different biological and psychological hypotheses have been proposed. Several clinical trials have been performed and, while some authors report no apparent association, the majority of the published data demonstrates a positive effect of physical exercise on both depressive symptoms and Quality of Life (QoL). In this review, the current status of exercise associated treatment of MDD is addressed, relevant data and models are discussed, and an updated view of the current situation is presented.
Keywords: Major depressive disorder, MDD, depression, physical exercise, physical activity, Omega-3 fatty acids, osteoporosis, seasonal effects, homozygotic, multigenic, angiogenic factor, Brain Derived Neurotrophic Factor (BDNF), Monoamine, Endorphin, Thermogenic
Current Psychopharmacology
Title: Physical Exercise and Major Depressive Disorder - Where Do We Stand?
Volume: 1
Author(s): Jorge Mota Pereira, Jorge Silverio, Serafim Carvalho, Joaquim Ramos and Jose Carlos Ribeiro
Affiliation:
Keywords: Major depressive disorder, MDD, depression, physical exercise, physical activity, Omega-3 fatty acids, osteoporosis, seasonal effects, homozygotic, multigenic, angiogenic factor, Brain Derived Neurotrophic Factor (BDNF), Monoamine, Endorphin, Thermogenic
Abstract: Depression is the most common mental disorder, affecting a large population worldwide. Of the psychiatric syndromes which present mood disorders, major depressive disorder (MDD) is one of the most severe due to the long periods of depressed mood, somatic symptoms, cognitive disturbances, clinically significant distress and impairment in everyday functioning. The causes of MDD are complex and associated with environmental and biological aspects. Treatment comprises structured forms of psychotherapy and antidepressant medication but remission rates are low and justify the implementation of an alternative effective treatment. Various authors have associated physical exercise with the treatment of depression and different biological and psychological hypotheses have been proposed. Several clinical trials have been performed and, while some authors report no apparent association, the majority of the published data demonstrates a positive effect of physical exercise on both depressive symptoms and Quality of Life (QoL). In this review, the current status of exercise associated treatment of MDD is addressed, relevant data and models are discussed, and an updated view of the current situation is presented.
Export Options
About this article
Cite this article as:
Mota Pereira Jorge, Silverio Jorge, Carvalho Serafim, Ramos Joaquim and Carlos Ribeiro Jose, Physical Exercise and Major Depressive Disorder - Where Do We Stand?, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020167
DOI https://dx.doi.org/10.2174/2211556011201020167 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
Neuromodulation for the treatment of psychiatric disorders
Neuromodulation techniques, including transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), magnetic seizure therapy (MST), electroconvulsive therapy (ECT), theta burst stimulation (TBS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS), have been widely employed in the therapeutic management of prevalent psychiatric conditions such ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
Current Drug Targets Endothelial Progenitor Cells as Potential Drug Targets
Current Drug Targets - Cardiovascular & Hematological Disorders Diagnosis of Von Willebrand Disease in Children
Current Pediatric Reviews Recurrent Left Atrial Low-grade Malignant Inflammatory Myofibroblastic Tumor Characterized by Cardiovascular Magnetic Resonance
Current Medical Imaging Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging Peripartum Cardiomyopathy: An Intriguing Challenge. Case Report with Literature Review
Current Cardiology Reviews Angiogenesis Inhibitors: Current & Future Directions
Current Pharmaceutical Design Prorenin and the (Pro)renin Receptor in Retinal Pathology
Current Hypertension Reviews Mechanical Circulatory Support of the Critically Ill Child Awaiting Heart Transplantation
Current Cardiology Reviews Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Antithrombotic Therapy for Peripheral Revascularisation
Current Vascular Pharmacology Regulation of the Sodium-Phosphate Cotransporter Pit-1 and its Role in Vascular Calcification
Current Vascular Pharmacology Hesperidin Potentiates Ghrelin Signaling
Recent Patents on Food, Nutrition & Agriculture Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin
Current Medicinal Chemistry Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Diagnosis and Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Redox Chemistry of Green Tea Polyphenols: Therapeutic Benefits in Neurodegenerative Diseases
Mini-Reviews in Medicinal Chemistry Is it the Time to Move Towards Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve Guided Percutaneous Coronary Intervention? The Pros and Cons
Current Cardiology Reviews